Oil prices hold near multi-week lows on demand worries
Oil prices edged up on Thursday, but held near multi-week lows hit overnight after U.S. data showed gasoline demand fell and recovery from the COVID-19...
Tag : GlaxoSmithKline
GSK and Sanofi to start human trials of potential Covid-19 vaccine
GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following promising results in earlier studies. GSK, the...
NSE: Trading sustains positive trend, up by 0.31 per cent
Activities on the Nigerian Stock Exchange (NSE) extended a positive trend on Tuesday with key market indices appreciating further by 0.31 per cent. Specifically, the...
NSE resumes trading for August with 0.30 per cent growth
The nation’s bourse commenced trading for August after Sallah break with a growth of 0.30 per cent on renewed bargain hunting. Specifically, the All Share...
Return to work: a sector-by-sector look at the plans of England’s major employers
Major companies in England have been told that, from 1 August, they can discuss with workers whether it is safe to return to work. Up...
Coronavirus: UK signs deal for 60m doses of potential vaccine
The government has signed a deal with the pharmaceutical firms GlaxoSmithKline (GSK) and Sanofi Pasteur for 60m doses of a potential Covid-19 vaccine. If the...
Covid-19 is Big Pharma’s chance to impress. But who’ll do best?
It was the press announcement heard around the world: a potential Covid-19 vaccine from the University of Oxford and pharmaceutical company AstraZeneca had not only...
Transactions close flat on NSE
Trading at the nation’s bourse closed flat on Wednesday with the All-Share Index (ASI), which opened at 24,174.45, closing at 24,173.53. Newsmen report that the...
GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley
Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But...